Dacomitinib: new treatment paradigm in the management of EGFR mutation positive NSCLC

Dr Chandrakanth M V, Medical Oncologist, Narayana Superspeciality Hospital, Kolkata, talks about the new treatment paradigm in the management of EGFR mutation positive NSCLC.


#Oncology #Cancer #NSCLC #Dacomitinib



20 views0 comments

Recent Posts

See All